輝瑞被指考慮「研發變種新冠病毒」 公司否認 - dofaq.co
《血友病》要價350萬美元!! FDA核准輝瑞(Pfizer)一次性基因療法Beqvez (fidanacogene elaparvovec-dzkt)治療成人B型 ...
Genet觀點 - 28 Apr 2024
《血友病》要價350萬美元!! FDA核准輝瑞(Pfizer)一次性基因療法Beqvez (fidanacogene elaparvovec-dzkt)治療成人B型 ... ...
針對B型血友病!美國食藥局批准輝瑞基因療法定價高達1億元| 聯合新聞網
聯合新聞網 - 27 Apr 2024
針對B型血友病!美國食藥局批准輝瑞基因療法定價高達1億元| 聯合新聞網 ...
《生技投資》英國製藥巨頭羅氏在美國控告輝瑞(Pfizer)和BioNTech 專利侵權兩家公司股價各跌3.84%和1.57% - 生技投資 ...
Genet觀點 - 25 Apr 2024
《生技投資》英國製藥巨頭羅氏在美國控告輝瑞(Pfizer)和BioNTech 專利侵權兩家公司股價各跌3.84%和1.57% - 生技投資 ... ...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters - 25 Apr 2024
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology ...
Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB
Fierce Pharma - 26 Apr 2024
Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB ...
Comparing the COVID-19 Vaccines: How Are They Different?
Yale Medicine - 24 Apr 2024
Comparing the COVID-19 Vaccines: How Are They Different? ...
Pfizer and BioNTech commence legal action against Moderna in UK court
Pharmaceutical Technology - 24 Apr 2024
Pfizer and BioNTech commence legal action against Moderna in UK court ...
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics
Yahoo Finance - 26 Apr 2024
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics ...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
The Dallas Morning News - 28 Apr 2024
The Motley Fool: Pfizer offers a pfat 6.4% dividend ...
Is Pfizer Stock, At An 11-Year Low, A Sell Amid The Search For Its Big Break?
Investor's Business Daily - 24 Apr 2024
Is Pfizer Stock, At An 11-Year Low, A Sell Amid The Search For Its Big Break? ...
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty
BioSpace - 26 Apr 2024
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty ...
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
CNBC - 26 Apr 2024
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder ...
Pfizer faces vote on human rights proposal | Governance intelligence
| Governance intelligence - 05 Mar 2024
Pfizer faces vote on human rights proposal | Governance intelligence ...
Tackling Antibiotic Resistance
Pfizer - 10 Apr 2024
Tackling Antibiotic Resistance ...
GSK: Pfizer, BioNTech 'reaped billions of dollars' from stealing COVID-19 patents
Life Sciences Intellectual Property Review - 26 Apr 2024
GSK: Pfizer, BioNTech 'reaped billions of dollars' from stealing COVID-19 patents ...
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose
Fierce Pharma - 26 Apr 2024
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose ...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters - 23 Apr 2024
Pfizer vs Moderna battle over COVID vaccine patents begins in UK ...
EC approves Pfizer's EMBLAVEO for multidrug-resistant infections
Pharmaceutical Technology - 23 Apr 2024
EC approves Pfizer's EMBLAVEO for multidrug-resistant infections ...
US FDA approves Pfizer's gene therapy for rare bleeding disorder
Reuters - 26 Apr 2024
US FDA approves Pfizer's gene therapy for rare bleeding disorder ...
GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit
Fierce Pharma - 26 Apr 2024
GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit ...